维普中文期刊产品整合服务
160篇 您的检索式:作者名="Tracey L"
    题名 作者 年代 出处 被引量
1Colorectal cancer in patients under 50 years of age:A retrospective analysis of two institutions' experience显示文摘AIM:To investigate the epidemiological characteristics of colorectal cancer(CRC)in patients under 50 years of age across two institutions.METHODS:Records of patients under age 50 years of age who had CRC surgery over a 16 year period were assessed at two institutions.The following documents where reviewed:admission notes,operative notes,and discharge summaries.The main study variables included:age,presenting symptoms,family history,tumor location,operation,stage/differentiation of disease,and post operative complications.Stage of disease was classified according to the American Joint Committee on Cancer TNM staging system:tumor depth;node status;and metastases.RESULTS:CRC was found in 180 patients under age50 years(87 females,93 males;mean age 41.4±6.2years).Young patients accounted for 11.2%of cases during a 6 year period for which the full data set wasavailable.Eight percent had a 1stdegree and 12%a 2nd degree family CRC history.Almost all patients(94%)were symptomatic at diagnosis;common symptoms included:bleeding(59%),obstruction(9%),and abdominal/rectal pain(35%).Evaluation was often delayed and bleeding frequently attributed to hemorrhoids.Advanced stage CRC(Stage 3 or 4)was noted in 53%of patients.Most tumors were distal to the splenic flexure(77%)and 39%involved the rectum.Most patients(95%)had segmental resections;6 patients had subtotal/total colectomy.Poorly differentiated tumors were noted in 12%and mucinous lesions in 19%of patients of which most had Stage 3 or 4 disease.Twenty-two patients(13%)developed recurrence and/or progression of disease to date.Three patients(ages 42,42and 49 years)went on to develop metachronous primary colon cancers within 3 to 4 years of their initial resection.CONCLUSION:CRC was common in young patients with no family history.Young patients with symptoms merit a timely evaluation to avoid presentation with late stage CRC.Elizabeth A Myers Daniel L Feingold Kenneth A Forde Tracey Arnell Joon Ho Jang Richard L Whelan 2013World Journal of Gastroenterology2013,19,34:9
2Bcl-2 expression in endometrial hyperplasia and carcinoma显示文摘Theodorf H Niemannn MD Tracey L 1996Gynecol Oncol1996,63,:1
3Noxious hot and cold stimulation produce common patterns of brain activation in humans: A functional magnetic resonance imaging study显示文摘Tracey I Becerra L Chang I 2000Neurosci Lett2000,288,2:1
4MicroRNA- 34a is a potent tumor suppressor molecule in vivo in neuroblastoma 显示文摘Tivnan A Tracey L Buckley PG 2011BMC Cancer2011,11,:1
5The 'cytokine profile': a code for sepsis 显示文摘Ulloa L Tracey KJ 2005Trends Mol Med2005,11,2:1
6CrystallisationKinetics of Novel Branched Poly(ethylene terephthalate) : a Small-angle X-ray Scattering Study显示文摘Tracey L H John S F David S 2006Polymer Interna- tional2006,55,:1
7A Reexamination of the Effects of Just-In-Time on Inbound Logistics显示文摘TRACEY M TAN C L VONDEREMBSE M 1995International Journal of Logistics Management1995,,2:1
8Adaptive disk spin-down for mobile computers显示文摘David P Helmbold Darrell D E Long Tracey L Sconyers Bruce Sherrod 2000Mobile Networks and Applications2000,5,4:1
9Updating the study of punishment 显示文摘Tracey L Meares 2004Stanford Law Review2004,24,11:1
10Expression of the NF-kappa B targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively 显示文摘Tracey L Perez-Rosado A Artiga M J 2005J Pathol2005,206,2:1
11Tumor necrosis factor antagonist mechanisms of action: a comprehensive review 显示文摘Tracey D Klareskog L Sasso EH 2008Pharmacol Ther2008,117,2:1
12The 'cytokine profile': a code for sepsis显示文摘Ulloa L Tracey KJ 2005Trends Mol Med2005,11,2:1
13Emotional states of athletes prior to performance-induced injury显示文摘TRACEY J D ANDREW M L YURI L H 2005J Sports Sci Med2005,4,:1
14The 'cytokine profile' : a code for sepsis 显示文摘Ulloa L Tracey K J 2005Trends Mol Med2005,11,:1
15MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma显示文摘Tivnan A Foley NH Tracey L 2010Anticancer Res2010,30,11:1
16The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2显示文摘Emmanuel Bourdon Dae-Kyung Kang Manik C Ghosh Steven K Drake Jane Wey Rodney L Levine Tracey A Rouault 2003Blood Cells, Molecules and Diseases2003,,2:1
17Alliances, networks and competitive strategy: rethinking cluster of innovation 显示文摘Tracey P & G L Clark 2003Growth and Change2003,34,1:1
18MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma显示文摘Tivnan A Tracey L Buckley PG 2011BMC Cancer2011,11,1:1
19Perspective-Alliances,Networks and Competitive Strategy,Rethinking Cluster of Innovation显示文摘Paul Tracey Gordon L Clark 2003Growth and Change2003,34,8:1
20MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma显示文摘Tivnan A Tracey L Buckley P G 2011BMC Cancer2011,11,33:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费